The authors specifically note the lack of randomized managed trials for orthopaedic indications—meaning we are able to’t confidently say it works, what the real facet-effect profile is, or what a “safe dose” could be in the real globe (systematic evaluation, 2024).BPC 157 provides a twin profit here. It protects the gut in the ulcers due to